M Ventures

What they do

M Ventures is the strategic corporate venture capital fund of Merck, investing in biotechnology and technology companies. It focuses on healthcare drug development, life science tools, electronics, and frontier technology and sustainability. The firm backs visionary companies developing solutions to treat challenging diseases, empower scientists with advanced research tools, transform information processing and display, and address complex sustainability and technology convergence challenges. M Ventures takes an active role in its portfolio, partnering with entrepreneurs and co-investors to translate innovation into commercial success.

What they look for

M Ventures invests globally in biotechnology and technology companies across healthcare drug development, life science tools, electronics, and frontier technology and sustainability, with both strategic and financial objectives. It targets visionary, often early-stage, companies developing disruptive tools, therapies, and digital and hardware solutions that leverage Merck’s expertise at the intersection of health, advanced materials, and information technologies.

Stage

Seed, Series A, Series B+

Sectors

Climate, Deeptech, Healthcare

Based

Amsterdam, NL